Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.10

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.10, versus ($0.10) reported last year. Revenue for the quarter came in at $9.3 million, versus $8.05 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Limoneira sells vineyard property for $15M at public auction
• CalPrivate Bank names Andra Frazier as chief credit officer